Hikma Pharmaceuticals Share News (HIK)

LONDON MARKET OPEN: Stocks Add To Trump Bounce

TOP NEWS: Hikma Pharmaceuticals Trims Revenue Guidance For 2016

Hikma Pharmaceuticals nudges down FY revenue guidance

(ShareCast News) - Hikma Pharmaceuticals said on Thursday that it is currently generating "good" revenue growth, but it nudged down its full-year revenue guidance, saying it now expects it to rise by around 35% to $2bn at constant currency, down from a previous range of $2bn to $2.1bn. The injectabl

Britain's FTSE recovers from Trump shock to hit one-week high

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 index closes 1 pct higher * Miners, pharma stocks rally * U.S.-exposed firms also gain By Atul Prakash and Kit R

Sector movers: Miners, US election-related plays lead gains

(ShareCast News) - Steel and mining stocks led gains for another session, amid widespread gains for most base metals and coal, helped by an initial bout of weakness in the US dollar. As of 1650 GMT, the US dollar was trading higher by 0.47% to 98.32 points after having earlier hit an intra-day low a

UPDATE 1-Construction, pharma, gold miners seen as Europe's top Trump trades

(Adds extra companies) LONDON, Nov 9 (Reuters) - Global markets reacted on Wednesday with concern to Donald Trump's surprise victory in the U.S. presidential election, but construction, pharma and gold mining stocks emerged as big winners in the European trading session. Gains in thos

Construction, pharma, gold miners seen as Europe's top Trump trades

LONDON, Nov 9 (Reuters) - Global markets reacted nervously on Wednesday to Donald Trump's surprise victory in the U.S. presidential election, but construction, pharma and gold mining stocks emerged as big winners in the European trading session. Gains in those three sectors helped pull Euro

LONDON MARKET MIDDAY: US Stocks Pointed Lower After Trump's Victory

Britain's FTSE dips after Trump win though pharma, gold miners surge

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 down 0.1 pct * Gold miners, pharma stocks rally * U.S.-exposed firms also gain By Kit Rees LONDON, Nov 9 (

European shares mark worst week since Feb as pharma stocks come under fire

* STOXX 600 down 0.8 pct * Drugmakers fall as U.S. lawmakers seek price fixing probe * Richemont among top gainers after results, management revamp * But JC Decaux falls on negative rev growth outlook (Adds details and updates prices at close) By Kit Rees and Danilo Maso

Broker tips: Aggreko, Hikma, Croda

(ShareCast News) - Morgan Stanley upgraded power generator company Aggreko from 'underweight' to 'equal weight' and bumped up its target price from 850p to 900p, despite orders for diesel products falling. "We retain our concerns over long-term pressures on the International power Projects (IPP) bus

Numis upgrades rating on Hikma Pharmaceutical but cuts target price

(ShareCast News) - Numis on Friday upgraded its rating on Hikma Pharmaceutical to 'buy' from 'hold' but cut its target price to 2,350p from 2,660p. Hikma's shares have fallen 35% over the past three months and significantly underperformed UK Mid-Cap Healthcare and Global Specialty Pharma, Numis high

European shares fall as pharma stocks come under fire; Richemont rallies

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon - see cpurl://apps.cp./cms/?pageId=livemarkets) Adds details, updates prices) * STOXX 600 down 1 pct, set for biggest weekly fall since Feb * Drugmakers fall as US lawmakers seeks p

European shares weighed down by pharma stocks; Richemont rallies

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon - see cpurl://apps.cp./cms/?pageId=livemarkets) MILAN, Nov 4 (Reuters) - European shares fell in early trade on Friday weighed down by weaker drugmakers after two U.S. lawmakers called on

BUZZ-Hikma: top Stoxx loser as HSBC cuts TP on DoJ market probe

** Hikma Pharma -c.7% in heavy vols, biggest loser on Stoxx & trading at lowest in 10 mnths as HSBC cuts TP to 1985p from 2525p ** HSBC says co not known for involvement in U.S. DoJ probe into generic drug price collusion, but all generic drugmakers may be viewed as guilty by association un